Cargando…

Who has anaphylaxis in Brazil? Validation of a questionnaire for population studies

BACKGROUND: The incidence of anaphylaxis is increasing in several parts of the world; thus, determining the prevalence of the disease in a given region is important to understand the factors involved and to promote measures to avoid this type of allergic reaction. Aiming this objective, we validated...

Descripción completa

Detalles Bibliográficos
Autores principales: Gagete, Elaine, Delazari dos Santos, Lucilene, Gomes de Pontes, Leticia, Morato Castro, Fábio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5679362/
https://www.ncbi.nlm.nih.gov/pubmed/29158870
http://dx.doi.org/10.1186/s40413-017-0171-2
_version_ 1783277574098518016
author Gagete, Elaine
Delazari dos Santos, Lucilene
Gomes de Pontes, Leticia
Morato Castro, Fábio
author_facet Gagete, Elaine
Delazari dos Santos, Lucilene
Gomes de Pontes, Leticia
Morato Castro, Fábio
author_sort Gagete, Elaine
collection PubMed
description BACKGROUND: The incidence of anaphylaxis is increasing in several parts of the world; thus, determining the prevalence of the disease in a given region is important to understand the factors involved and to promote measures to avoid this type of allergic reaction. Aiming this objective, we validated an instrument for a population-basedstudy that assesses the prevalence of anaphylaxis in the Brazilian population. METHODS: A questionnaire was generated in two variants - one for subjects seven years old or above (Group A) and another for children who were up to six years, 11 months and 29 days (Group B). The instrument was administered to patients with and without anaphylaxis. By allocating points, a score was calculated to differentiate subjects with and without the disease. After validation, the questionnaire was applied in the city of Botucatu (São Paulo state, Brazil), by randomly selecting houses and inviting residents to answer the questionnaire. RESULTS: The questionnaire was reliable for identifying subjects with and without anaphylaxis in both groups, with a specificity and sensitivity above 90%. The prevalence of anaphylaxis in the pilot survey was 6.2% in Group A, however the evaluation was compromised in Group B by the low number of children below seven years of age due to random sampling of residences. DISCUSSION: The prevalence of anaphylaxis in our pilot test (6.2%) was similar to major epidemiological surveys from several parts of the world, showing that anaphylaxis is not a rare disease. The instrument of the present work was suitable for this epidemiological survey and might be a good option for studying anaphylaxis in other populations. CONCLUSION: This instrument might be of particular value in places where researchers cannot access medical records to conduct similar epidemiological studies.
format Online
Article
Text
id pubmed-5679362
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-56793622017-11-20 Who has anaphylaxis in Brazil? Validation of a questionnaire for population studies Gagete, Elaine Delazari dos Santos, Lucilene Gomes de Pontes, Leticia Morato Castro, Fábio World Allergy Organ J Original Research BACKGROUND: The incidence of anaphylaxis is increasing in several parts of the world; thus, determining the prevalence of the disease in a given region is important to understand the factors involved and to promote measures to avoid this type of allergic reaction. Aiming this objective, we validated an instrument for a population-basedstudy that assesses the prevalence of anaphylaxis in the Brazilian population. METHODS: A questionnaire was generated in two variants - one for subjects seven years old or above (Group A) and another for children who were up to six years, 11 months and 29 days (Group B). The instrument was administered to patients with and without anaphylaxis. By allocating points, a score was calculated to differentiate subjects with and without the disease. After validation, the questionnaire was applied in the city of Botucatu (São Paulo state, Brazil), by randomly selecting houses and inviting residents to answer the questionnaire. RESULTS: The questionnaire was reliable for identifying subjects with and without anaphylaxis in both groups, with a specificity and sensitivity above 90%. The prevalence of anaphylaxis in the pilot survey was 6.2% in Group A, however the evaluation was compromised in Group B by the low number of children below seven years of age due to random sampling of residences. DISCUSSION: The prevalence of anaphylaxis in our pilot test (6.2%) was similar to major epidemiological surveys from several parts of the world, showing that anaphylaxis is not a rare disease. The instrument of the present work was suitable for this epidemiological survey and might be a good option for studying anaphylaxis in other populations. CONCLUSION: This instrument might be of particular value in places where researchers cannot access medical records to conduct similar epidemiological studies. BioMed Central 2017-11-08 /pmc/articles/PMC5679362/ /pubmed/29158870 http://dx.doi.org/10.1186/s40413-017-0171-2 Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Original Research
Gagete, Elaine
Delazari dos Santos, Lucilene
Gomes de Pontes, Leticia
Morato Castro, Fábio
Who has anaphylaxis in Brazil? Validation of a questionnaire for population studies
title Who has anaphylaxis in Brazil? Validation of a questionnaire for population studies
title_full Who has anaphylaxis in Brazil? Validation of a questionnaire for population studies
title_fullStr Who has anaphylaxis in Brazil? Validation of a questionnaire for population studies
title_full_unstemmed Who has anaphylaxis in Brazil? Validation of a questionnaire for population studies
title_short Who has anaphylaxis in Brazil? Validation of a questionnaire for population studies
title_sort who has anaphylaxis in brazil? validation of a questionnaire for population studies
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5679362/
https://www.ncbi.nlm.nih.gov/pubmed/29158870
http://dx.doi.org/10.1186/s40413-017-0171-2
work_keys_str_mv AT gageteelaine whohasanaphylaxisinbrazilvalidationofaquestionnaireforpopulationstudies
AT delazaridossantoslucilene whohasanaphylaxisinbrazilvalidationofaquestionnaireforpopulationstudies
AT gomesdepontesleticia whohasanaphylaxisinbrazilvalidationofaquestionnaireforpopulationstudies
AT moratocastrofabio whohasanaphylaxisinbrazilvalidationofaquestionnaireforpopulationstudies